Skip to Content
Trade options on Composer. Earn up to $200 in cash rebates!Get Started.T&Cs apply.
Symphonies
BioTech v1 185 | 10 | 2025
Today’s Change
—

A symphony is an automated trading strategy — Learn more about symphonies here

About

Trend-based biotech strategy: when ARKG (a genomics ETF) is in an uptrend, own 7 strong biotech/health names equally. Otherwise hold one defensive ETF (bonds or defensive sectors), picking the most recently oversold. Rebalanced daily.
NutHow it works
It checks a biotech “thermometer”: ARKG, a genomics/biotech ETF. If ARKG’s short‑term average price is above its long‑term average, it buys 7 biotech/health names showing the strongest recent buying (RSI, a 0–100 score of recent buying vs selling), split evenly. If not, it moves into one safer ETF (bonds or defensive sectors), choosing the one that’s recently fallen the most (lowest RSI). Rebalanced daily.
CheckmarkValue prop
Out-of-sample, this biotech trend strategy beats the S&P on risk-adjusted terms: oos Sharpe ~2.13, Calmar ~10.68, and ~80% annualized return, with 7 biotech names in uptrends and a defensive safety net for downside control.
1M
3M
6M
YTD
1Y
3Y
Max
www.composer.trade
Performance
Compared to selected benchmarks
AlphaBetaR2R
SPY
0.531.420.150.39
Performance Metrics
Cumulative ReturnAnnualized ReturnTrailing 1M ReturnTrailing 3M ReturnSharpe Ratio
SPY
13.69%25.57%2.19%5.01%2.24
BioTech v1 185 | 10 | 2025
55.16%118.06%0.2%5.6%2.23
Initial Investment
$10,000.00
Final Value
$15,516.38
Regulatory Fees
$17.84
Total Slippage
$70.65
Invest in this strategy
OOS Start Date
Nov 18, 2025
Trading Setting
Daily
Type
Stocks
Category
Trend-following,momentum,biotech/healthcare,tactical rotation,defensive allocation,daily rebalance
Tickers in this symphonyThis symphony trades 41 assets in total
Ticker
Type
ABCL
AbCellera Biologics Inc. Common Shares
Stocks
ABSI
Absci Corporation Common Stock
Stocks
ALIT
Alight, Inc.
Stocks
ALNY
Alnylam Pharmaceuticals, Inc.
Stocks
AMGN
Amgen Inc
Stocks
ANGL
VanEck Fallen Angel High Yield Bond ETF
Stocks
ARKG
ARK Genomic Revolution ETF
Stocks
ATOM
Atomera Incorporated Common Stock
Stocks
BFLY
Butterfly Network, Inc.
Stocks
BSV
Vanguard Short-Term Bond ETF
Stocks

FAQ

A Composer symphony is an automated trading strategy that executes trades based on parameters of your choice. Some symphonies are similar to holding one ETF in normal conditions and rotating to a different ETF when market conditions shift, for example a 5% drop in the S&P 500, while others use complex rules with dozens of triggers. However, complex doesn’t always mean better. A simple, well-structured symphony can be just as effective as an intricate one. Learn more about how symphonies work here.

"BioTech v1 185 | 10 | 2025" is currently performing the same as yesterday today. Performance updates in real time during market hours.

"BioTech v1 185 | 10 | 2025" is currently allocated toEXAS, WELL, SLP, DXCM, MASI, BFLYandEVO. Holdings automatically adjust as market conditions change based on the strategy's rules.

Year-to-date, "BioTech v1 185 | 10 | 2025" has returned 80.46%. You can adjust the performance chart above to view returns across different time horizons.

The maximum drawdown for "BioTech v1 185 | 10 | 2025" is 7.53%. The maximum drawdown measures the largest peak-to-trough decline. It's an important metric to evaluate risk and the strategy's behavior during market stress.

To invest in "BioTech v1 185 | 10 | 2025", simply click the Invest button on this page. You'll need to open an account with Composer if you don't have one yet, then you can start investing. Composer will automatically execute the trades for you based on the strategy's rules. Composer also supports trading individual stocks, ETFs, crypto, and options.